December 22, 2009
The International Pig Veterinary Society Congress is an
important venue for gathering leading swine veterinarians and
researchers globally to discuss best-practices in pig breeding and
handling.
For the second time in four years, Pharmacosmos is proud to be
industrial supporter of the IPVS Congress held in Vancouver,
Canada, July 18 - July 21, 2010.
Mogens Toftegaard Petersen, Regional Veterinary Business Manager
at Pharmacosmos, comments: "Timely and effective iron injection
for prevention of iron deficiency in piglets is a well-established
practice in modern pig production management. Today, we know that
injectable iron therapy in faster growing piglets can be optimized
and lead to improved production performance. IPVS is an important
venue where new developments in production management are
established. By supporting the IPVS 2010, we are pleased to
contribute to bringing awareness to best-practices that help
pig-breeders worldwide optimize their production
management."
Last time Pharmacosmos supported the IPVS was in 2006, when the
congress was held in Copenhagen, Denmark.
For more information about the IPVS 2010, please visit www.ipvs2010.com.
About Uniferon
Uniferon is a modern improved iron hydrogenated dextran based on
a natural formula, which is approved for global use:
Uniferon is manufactured without the use of any organic solvents
or cyanide, thus, avoiding trace residues of these impurities.
Pharmacosmos manufactures iron dextran of high quality and unique
purity for customers worldwide. Uniferon is the only injectable
iron brand for piglets approved in the EU, the US and Asia.
About Pharmacosmos
Headquartered in Denmark, Pharmacosmos is a family-owned,
international healthcare company with more than 50 years of
innovation and leadership in iron- and carbohydrate-based
treatments and solutions for human and animal use.
A research-based company, its ongoing R&D programme focuses
on improving the lives of patients with iron deficiency with or
without anaemia. More than 1 billion people live with iron
deficiency anaemia and it is the leading cause of death for an
estimated 180,000 people every year. This makes it one of the
largest global health challenges of our time.
Pharmacosmos has subsidiaries in the Nordics, the UK and the US
and its products are marketed in more than 80 countries across the
world. Its manufacturing facilities are approved, among others, by
the Danish Medicines Agency and the US FDA.